GGrantIndex
← Leaderboards

Mukund Seshadri

Roswell Park Cancer Institute Corp

$11,493,912
Attributed
$11,634,903
Total exposure
11
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.7M · FY201025
$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,634,903 · 11

By mechanism

R01$6,885,869 · 3
S10$2,596,032 · 2
P30$1,012,400 · 3
R56$471,502 · 1
R21$387,117 · 1
R25$281,983 · 1

Top collaborators

Most similar at Roswell Park Cancer Institute Corp

Same institution · by research overlap

Others in their field

Top investigators on “Future

Research focus

FutureMalignant NeoplasmsEvaluationPre-ClinicalTumorResponseImaging ModalityAnimalsInvestigationIn VivoFunctional ImagingResearch Clinical TestingRadiology SpecialtyResearch PersonnelBiologyImageComprehensive Cancer CenterQuality Of LifeBaseInterestMolecularNon-Invasive ImagingOncologyExhibits

Grant awards (29)

Radiogenomic Credentialing of Head and Neck Cancer Models$574,775
R01 · FY2025 · CA · contact PI
Cancer Research Training and Education Coordination$372,411
P30 · FY2025 · CA · contact PI
Summer Research Experiences in Quantitative Cancer Sciences and Emerging Technologies$281,983
R25 · FY2025 · CA
Radiogenomic Credentialing of Head and Neck Cancer Models$552,668
R01 · FY2024 · CA · contact PI
Cancer Research Training and Education Coordination$155,429
P30 · FY2024 · CA · contact PI
Radiogenomic Credentialing of Head and Neck Cancer Models$583,802
R01 · FY2023 · CA · contact PI
Cancer Research Career Enhancement and Related Activities$76,811
P30 · FY2023 · CA · contact PI
Translational Imaging Shared Resource$76,809
P30 · FY2023 · CA · contact PI
Radiogenomic Credentialing of Head and Neck Cancer Models$597,483
R01 · FY2022 · CA · contact PI
Radiation-induced Salivary Gland Vascular Injury: Mechanisms and Interventions$471,502
R56 · FY2022 · DE · contact PI
Translational Imaging Shared Resource$80,797
P30 · FY2022 · CA · contact PI
Acquisition of a 7T MR scanner for Translational Imaging Research at Roswell Park$2,000,000
S10 · FY2021 · OD · contact PI
Radiogenomic Credentialing of Head and Neck Cancer Models$623,637
R01 · FY2021 · CA · contact PI
Translational Imaging Shared Resource$83,381
P30 · FY2021 · CA · contact PI
Impact of Vitamin D on the Chemopreventive Efficacy of Erlotinib against Oral Cancer$428,750
R01 · FY2020 · DE · contact PI
Impact of Vitamin D on the Chemopreventive Efficacy of Erlotinib against Oral Cancer$252,300
R01 · FY2020 · DE · contact PI
Translational Imaging Shared Resource$83,381
P30 · FY2020 · CA · contact PI
Impact of Vitamin D on the Chemopreventive Efficacy of Erlotinib against Oral Cancer$428,750
R01 · FY2019 · DE · contact PI
Non-invasive assessment of salivary gland function: Translational Studies$380,536
R01 · FY2019 · CA · contact PI
Translational Imaging Shared Resource$83,381
P30 · FY2019 · CA · contact PI
Impact of Vitamin D on the Chemopreventive Efficacy of Erlotinib against Oral Cancer$428,750
R01 · FY2018 · DE · contact PI
Non-invasive assessment of salivary gland function: Translational Studies$392,306
R01 · FY2018 · CA · contact PI
Impact of Vitamin D on the Chemopreventive Efficacy of Erlotinib against Oral Cancer$428,750
R01 · FY2017 · DE · contact PI
Non-invasive assessment of salivary gland function: Translational Studies$392,306
R01 · FY2017 · CA · contact PI
Impact of Vitamin D on the Chemopreventive Efficacy of Erlotinib against Oral Cancer$428,750
R01 · FY2016 · DE · contact PI
Non-invasive assessment of salivary gland function: Translational Studies$392,306
R01 · FY2016 · CA · contact PI
Photoacoustic Micro-Imaging system for Shared Tumor Imaging Resource at Roswell P$596,032
S10 · FY2012 · OD · contact PI
DEVELOPMENT AND VALIDATION OF AN IMAGING-BASED BIOMARKER OF THERAPEUTIC EFFICACY$202,442
R21 · FY2011 · CA · contact PI
DEVELOPMENT AND VALIDATION OF AN IMAGING-BASED BIOMARKER OF THERAPEUTIC EFFICACY$184,675
R21 · FY2010 · CA · contact PI